Schellenberg Wittmer advised Boehringer Ingelheim on its acquisition of Evax AG

25.08.2026

Schellenberg Wittmer advised Boehringer Ingelheim, one of the largest pharmaceutical companies, on the acquisition of Evax AG. Evax AG is a Swiss biotech company focused on equine health.

Show more

 

Schellenberg Wittmer acts as Swiss counsel to Enilive on its acquisition of OIL!’s fuel service stations in Europe

23.07.2026

Schellenberg Wittmer acts as Swiss counsel to Enilive on its acquisition of all shares in OIL! Tankstellen GmbH, a company operating in the mobility retail business in Germany, …

Show more

 

Schellenberg Wittmer advised Brütsch Technology AG on the sale-and-leaseback of its headquarter in Beringen

07.07.2026

‎

Show more

 

Schellenberg Wittmer advises OC Oerlikon on new bond issuance

29.05.2026

Schellenberg Wittmer advised OC Oerlikon as lead counsel on its placement of CHF 200 million senior unsecured bonds.

Show more

 

Schellenberg Wittmer acted as Swiss legal counsel to the joint lead managers in Amazon's inaugural CHF 2.820 bn bond issue

28.05.2026

BNP Paribas, Deutsche Bank, and J.P. Morgan Securities acted as joint lead managers in the successful inaugural placement in Switzerland of six tranches of bonds issued by Amazon …

Show more